阿比特龙
Men in both studies were given 1000mg of abiraterone daily. 两个研究中的男患者每日均口服1000mg阿比特龙。
Men in both studies were gien 1000mg of abiraterone daily. 两个研究中的男患者每日均口服1000mg阿比特龙。
Phase III trial of abiraterone is planned for next year. 阿比特龙的III期试验计划在明年进行。
Ten of these men have seen PSA declines of more than 50% that have lasted at least 3 months from the start of taking abiraterone, with no major toxicities or adverse events. 其中10名患者在坚持服用阿比特龙至少3个月后，PSA下降超过50%25，没有严重毒性或不良事件发生。
Ten of these men hae seen PSA declines of more than 50% that hae lasted at least 3 months from the start of taking abiraterone, with no major toxicities or aderse eents. 其中10名患者在坚持服用阿比特龙至少3个月后，PSA下降超过50%25，没有严重毒性或不良事件发生。
